SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008230
Filing Date
2022-05-11
Accepted
2022-05-11 07:33:48
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cgtx-20220331x10q.htm   iXBRL 10-Q 1215295
2 EX-31.1 cgtx-20220331xex31d1.htm EX-31.1 16276
3 EX-31.2 cgtx-20220331xex31d2.htm EX-31.2 16786
4 EX-32.1 cgtx-20220331xex32d1.htm EX-32.1 9966
5 EX-32.2 cgtx-20220331xex32d2.htm EX-32.2 10004
  Complete submission text file 0001558370-22-008230.txt   5254670

Data Files

Seq Description Document Type Size
6 EX-101.SCH cgtx-20220331.xsd EX-101.SCH 34032
7 EX-101.CAL cgtx-20220331_cal.xml EX-101.CAL 49219
8 EX-101.DEF cgtx-20220331_def.xml EX-101.DEF 140101
9 EX-101.LAB cgtx-20220331_lab.xml EX-101.LAB 381679
10 EX-101.PRE cgtx-20220331_pre.xml EX-101.PRE 279294
50 EXTRACTED XBRL INSTANCE DOCUMENT cgtx-20220331x10q_htm.xml XML 819190
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40886 | Film No.: 22912091
SIC: 2836 Biological Products, (No Diagnostic Substances)